← Open Payments lookup

AYESHA GULISTAN: Open Payments

NPI 1609105386 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,426 in 57 payments from 17 companies in 2025. Trend: 2023 $841 · 2024 $1,106 · 2025 $1,426

Food & beverage: $1,426
CompanyPaymentsAmount
Novo Nordisk Inc9$214
AstraZeneca Pharmaceuticals LP10$184
Bayer Healthcare Pharmaceuticals Inc.3$162
ABBVIE INC.6$130
Corcept Therapeutics1$125
Inspire Medical Systems, Inc.1$101
PFIZER INC.5$99
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$92
Lilly USA, LLC5$90
Astellas Pharma US Inc3$68

Products named: Kerendia, Korlym, Ozempic, INSPIRE, XIFAXAN, VRAYLAR, JARDIANCE, AIRSUPRA.

Industry payments across MD — which companies pay providers there.